SCHEMBL7512362

SCHEMBL7512362

COc1ccc(C(=O)NC#N)cc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2C9 P11712 1/20 0.58
TSHR P16473 1/20 0.58
CYP2C19 P33261 1/20 0.58
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA4 P22748 1/20 0.56
CA6 P23280 1/20 0.56
CA7 P43166 1/20 0.56
TPMT P51580 1/20 0.56
CA9 Q16790 1/20 0.56
CA14 Q9ULX7 1/20 0.56
POLB P06746 3/20 0.56
MAPK1 P28482 2/20 0.56
HTT P42858 1/20 0.56
MAPT P10636 4/20 0.55
ALOX15 P16050 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8651942 0.86 ALDH1A1 (0.61) CYP3A4CA1CA2POLBMAPK1
SCHEMBL8632332 0.81 ALDH1A1 (0.63) CYP3A4TSHRPOLBMAPTKMT2A
Hydrochloric Acid SCHEMBL9638760 0.81 SMPD1 (0.64) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL12682342 0.80 MAPT (0.71) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL4151619 0.79 CYP1A2 (0.66) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL1436474 0.79 SMPD1 (0.66) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
Hydrochloric Acid SCHEMBL9638417 0.78 ALDH1A1 (0.66) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL11665996 0.77 CA1 (0.61) CYP1A2CYP3A4CYP2C9CYP2C19CA1
SCHEMBL2446906 0.77 CYP1A2 (0.63) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL6500203 0.77 CYP1A2 (0.63) CYP1A2CYP3A4CYP2C9TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462076-B2 CYSTEINE PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CYSTEINE PROTEASES, SUCH AS OSTEOPOROSIS, OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, TUMOR METASTASIS, ANGINA PECTORIS, PLAQUE RUPTURE AND STROKE ETC. HOFFMANN-LA ROCHE INC. 2002-10-08 US disclosed
EP-1244621-A1 NITRILE DERIVATIVES AS CATHEPSIN K INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-10-02 EP disclosed
WO-2001047886-A1 NITRILE DERIVATIVES AS CATHEPSIN K INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2001-07-05 WO disclosed